Multivessel obstructive coronary artery disease is observed in about half of the STEMI patients undergoing primary PCI. Optimal management of non-culprit lesions in these settings continues to be a matter of debate and no con
Special issue on PCR Valves e-Course; patient-centring the Heart Team, COVID and clinical trials...
Optimising the delivery of self-expanding valves according to vascular access
November 20, 2020